About this trial
The rotator cuff is a set of muscles and tendons that help move the shoulder. Tears in the rotator cuff are common, particularly as people age. Consequently, rotator cuff repair surgeries are common, as well. Despite the frequency with which rotator cuff repairs are performed, there remains a high rate of postoperative failure to heal. In such situations, there is a lack of connective tissue establishment between the rotator cuff tendon and the bone. One strategy to attempt to improve healing of the rotator cuff tendon back to the bone is via the use of extracellular matrix allograft. This treatment is composed of tissue from other humans, which is stripped of its cells so that just the scaffolding around the cells remains. This decellularized scaffolding can be placed at the rotator cuff healing site in an attempt to augment healing. Both animal studies and human studies have shown promise with this approach. Of those patients enrolling in the study, 50% will be assigned at random to receive a standard rotator cuff repair AND allograft treatment, while 50% will be assigned at random to receive standard rotator cuff repair WITHOUT allograft treatment. All patients enrolled in the study will also obtain an MRI at one year following surgery in order to assess tendon healing. Of note, one-year postoperative MRIs are not standard following rotator cuff repair - only those enrolled in the study will receive this MRI. There will be no financial consequence of receiving this MRI.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age ≥ 18 years
Diagnosis of full thickness rotator cuff tear
Disqualifiers
Partial thickness tears
Full thickness subscapularis tears
Goutallier grades 3 and 4
Prior rotator cuff surgery
Trial design
Parallel
Treatments tested in this trial
Rotator Cuff Repair with Allograft Patch
Other interventionRotator cuff repairs will be augmented with use of a decellularized human placental allograft patch
Rotator Cuff Repair with No Augmentation
Other interventionStandard rotator cuff repair with no augmentation
Treatment groups
Trial outcomes
Primary outcomes
Retear Rate
The primary outcome measure will be the postoperative retear rate, measured on one-year postoperative MRI
Secondary outcomes
Tendon Structural Continuity (MRI)
MRI Measurement of Tendon Structural Continuity
Tendon Thickness (MRI)
MRI measurement of tendon thickness
Constant-Murley score
The Constant-Murley score is a 100-point scale used to assess shoulder function, with a higher score indicating better function. The components include Pain (0 - 15 points), Activities of Daily Living (0 - 20 points), Range of Motion (0 - 40 points), and Strength (0 -25 points). The full score range is 0 to 100.
American Shoulder and Elbow Surgeons (ASES) score
The American Shoulder and Elbow Surgeons (ASES) score is a patient-reported assessment of shoulder pain and function. It ranges from 0 to 100, with higher scores indicating better function. The ASES score combines a pain component (assessed using a Visual Analogue Scale (VAS) that ranges from 0 - 50) and a functional component (10 items, 5 points each). The full score range is 0 to 100.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Columbia University
Lead sponsor
CTM Biomedical
Collaborator
This trial is not recruiting at the moment. You can still explore other options: